252 related articles for article (PubMed ID: 30135009)
1. Antibiotic-Resistant E. coli in Uncomplicated Community-Acquired Urinary Tract Infection.
Klingeberg A; Noll I; Willrich N; Feig M; Emrich D; Zill E; Krenz-Weinreich A; Kalka-Moll W; Oberdorfer K; Schmiemann G; Eckmanns T
Dtsch Arztebl Int; 2018 Jul; 115(29-30):494-500. PubMed ID: 30135009
[TBL] [Abstract][Full Text] [Related]
2. Resistance Patterns of Escherichia coli in Women with Uncomplicated Urinary Tract Infection Do Not Correlate with Emergency Department Antibiogram.
Hines MC; Al-Salamah T; Heil EL; Mallemat H; Witting MD; Johnson JK; Winters ME; Hayes BD
J Emerg Med; 2015 Dec; 49(6):998-1003. PubMed ID: 26281821
[TBL] [Abstract][Full Text] [Related]
3. Risk Factors for Trimethoprim and Sulfamethoxazole-Resistant Escherichia Coli in ED Patients with Urinary Tract Infections.
Wesolek JL; Wu JY; Smalley CM; Wang L; Campbell MJ
Am J Emerg Med; 2022 Jun; 56():178-182. PubMed ID: 35405469
[TBL] [Abstract][Full Text] [Related]
4. Antibiotic resistance in isolates recovered from women with community-acquired urinary tract infections presenting to a tertiary care emergency department.
Filiatrault L; McKay RM; Patrick DM; Roscoe DL; Quan G; Brubacher J; Collins KM
CJEM; 2012 Sep; 14(5):295-305. PubMed ID: 22967697
[TBL] [Abstract][Full Text] [Related]
5. TRIMETHOPRIM-SULFAMETHOXAZOLE RESISTANCE AND FOSFOMYCIN SUSCEPTIBILITY RATES IN UNCOMPLICATED URINARY TRACT INFECTIONS: TIME TO CHANGE THE ANTIMICROBIAL PREFERENCES.
Guneysel O; Suman E; Ozturk TC
Acta Clin Croat; 2016 Mar; 55(1):49-57. PubMed ID: 27333718
[TBL] [Abstract][Full Text] [Related]
6. Prevalence and risk factors for trimethoprim-sulfamethoxazole-resistant Escherichia coli among women with acute uncomplicated urinary tract infection in a developing country.
Gangcuangco LM; Alejandria M; Henson KE; Alfaraz L; Ata RM; Lopez M; Saniel M
Int J Infect Dis; 2015 May; 34():55-60. PubMed ID: 25748571
[TBL] [Abstract][Full Text] [Related]
7. Risk factors for ciprofloxacin resistance among Escherichia coli strains isolated from community-acquired urinary tract infections in Turkey.
Arslan H; Azap OK; Ergönül O; Timurkaynak F;
J Antimicrob Chemother; 2005 Nov; 56(5):914-8. PubMed ID: 16174685
[TBL] [Abstract][Full Text] [Related]
8. Urinary tract infection in women over the age of 65: is age alone a marker of complication?
Grover ML; Bracamonte JD; Kanodia AK; Edwards FD; Weaver AL
J Am Board Fam Med; 2009; 22(3):266-71. PubMed ID: 19429732
[TBL] [Abstract][Full Text] [Related]
9. Cranberries vs antibiotics to prevent urinary tract infections: a randomized double-blind noninferiority trial in premenopausal women.
Beerepoot MA; ter Riet G; Nys S; van der Wal WM; de Borgie CA; de Reijke TM; Prins JM; Koeijers J; Verbon A; Stobberingh E; Geerlings SE
Arch Intern Med; 2011 Jul; 171(14):1270-8. PubMed ID: 21788542
[TBL] [Abstract][Full Text] [Related]
10. Antimicrobial resistance patterns in outpatient urinary tract infections--the constant need to revise prescribing habits.
Bosch FJ; van Vuuren C; Joubert G
S Afr Med J; 2011 May; 101(5):328-31. PubMed ID: 21837876
[TBL] [Abstract][Full Text] [Related]
11. Extended-spectrum β-lactamase-producing Gram-negative pathogens in community-acquired urinary tract infections: an increasing challenge for antimicrobial therapy.
Meier S; Weber R; Zbinden R; Ruef C; Hasse B
Infection; 2011 Aug; 39(4):333-40. PubMed ID: 21706226
[TBL] [Abstract][Full Text] [Related]
12. Addressing antibiotic resistance.
Gupta K
Am J Med; 2002 Jul; 113 Suppl 1A():29S-34S. PubMed ID: 12113869
[TBL] [Abstract][Full Text] [Related]
13. Acute uncomplicated UTI and E. coli resistance: implications for first-line empirical antibiotic therapy.
Perfetto EM; Keating K; Merchant S; Nichols BR
J Manag Care Pharm; 2004; 10(1):17-25. PubMed ID: 14720102
[TBL] [Abstract][Full Text] [Related]
14. Increasing antimicrobial resistance and the management of uncomplicated community-acquired urinary tract infections.
Gupta K; Hooton TM; Stamm WE
Ann Intern Med; 2001 Jul; 135(1):41-50. PubMed ID: 11434731
[TBL] [Abstract][Full Text] [Related]
15. Prevalence and risk factor analysis of trimethoprim-sulfamethoxazole- and fluoroquinolone-resistant Escherichia coli infection among emergency department patients with pyelonephritis.
Talan DA; Krishnadasan A; Abrahamian FM; Stamm WE; Moran GJ;
Clin Infect Dis; 2008 Nov; 47(9):1150-8. PubMed ID: 18808361
[TBL] [Abstract][Full Text] [Related]
16. Outpatient antibiogram and predictors of ciprofloxacin and trimethoprim-sulfamethoxazole resistant urinary tract infections.
Valentine-King M; Zoorob R; Grigoryan L; Trautner B
Ann Fam Med; 2022 Apr; 20(20 Suppl 1):. PubMed ID: 36944052
[TBL] [Abstract][Full Text] [Related]
17. Fosfomycin tromethamine as second agent for the treatment of acute, uncomplicated urinary tract infections in adult female patients in The Netherlands?
Knottnerus BJ; Nys S; Ter Riet G; Donker G; Geerlings SE; Stobberingh E
J Antimicrob Chemother; 2008 Aug; 62(2):356-9. PubMed ID: 18424789
[TBL] [Abstract][Full Text] [Related]
18. Risk factors for trimethoprim-sulfamethoxazole resistance in patients with acute uncomplicated cystitis.
Colgan R; Johnson JR; Kuskowski M; Gupta K
Antimicrob Agents Chemother; 2008 Mar; 52(3):846-51. PubMed ID: 18086847
[TBL] [Abstract][Full Text] [Related]
19. Trimethoprim/sulfamethoxazole resistance in urinary tract infections.
Guneysel O; Onur O; Erdede M; Denizbasi A
J Emerg Med; 2009 May; 36(4):338-41. PubMed ID: 18325714
[TBL] [Abstract][Full Text] [Related]
20. Prevalence of antimicrobial resistant Escherichia coli from patients with suspected urinary tract infection in primary care, Denmark.
Córdoba G; Holm A; Hansen F; Hammerum AM; Bjerrum L
BMC Infect Dis; 2017 Oct; 17(1):670. PubMed ID: 29017466
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
